Tarsier Pharma Ltd. (TARX)

Tarsier Pharma Statistics

Total Valuation

Tarsier Pharma has a market cap or net worth of $258.63 million. The enterprise value is $263.25 million.

Market Cap	258.63M
Enterprise Value	263.25M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Tarsier Pharma has 28.74 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	28.74M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	34.68
EV / EBIT	34.70
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	0.87
Debt / FCF	n/a
Interest Coverage	3.02

Financial Efficiency

Return on equity (ROE) is -101.58%.

Return on Equity (ROE)	-101.58%
Return on Assets (ROA)	218.06%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.69M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.55M
Pretax Income	5.07M
Net Income	-5.07M
EBITDA	7.59M
EBIT	7.59M
Earnings Per Share (EPS)	-$0.18

Balance Sheet

The company has $2.00 million in cash and $6.62 million in debt, with a net cash position of -$4.62 million or -$0.16 per share.

Cash & Cash Equivalents	2.00M
Total Debt	6.62M
Net Cash	-4.62M
Net Cash Per Share	-$0.16
Equity (Book Value)	-4.99M
Book Value Per Share	-0.17
Working Capital	1.20M

Cash Flow

In the last 12 months, operating cash flow was -$1.32 million and capital expenditures -$1,000, giving a free cash flow of -$1.32 million.

Operating Cash Flow	-1.32M
Capital Expenditures	-1,000
Depreciation & Amortization	5,000
Net Borrowing	2.10M
Free Cash Flow	-1.32M
FCF Per Share	-$0.05

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Tarsier Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.96%
FCF Yield	-0.51%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a

Data Source: Official company filings

The statistics for upcoming IPOs are gathered manually by the Stock Analysis team, based on SEC filings and official company press releases.

Data Sources Report a data error